Here are the 8-K filings from Morgan Stanley Solana Trust (MSOL) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow MSOL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MSOL filings page.
Morgan Stanley Solana Trust said Sally Diffley resigned as Chief Financial Officer of Morgan Stanley Investment Management Inc., the Trust’s delegated sponsor, on October 30, 2026. Swapnil Parab is appointed Chief Financial Officer of the delegated sponsor effective November 4, 2026, succeeding Diffley.
Parab is Head of Financial Planning and Analysis for Morgan Stanley Investment Management. He joined Morgan Stanley’s Finance Division in 2009 and previously served as Head of Valuation Control for the Firm’s Fixed Income business within the Institutional Securities segment and for the Wealth and Investment Management segments. He holds an MBA from London Business School and a Bachelor of Technology degree in Electronics and Communications Engineering from the National Institute of Technology, India.
Morgan Stanley Solana Trust said its Delegated Sponsor, Morgan Stanley Investment Management Inc., announced that Craig Abruzzo would become Co-Chief Operating Officer and a director of the Delegated Sponsor, effective October 1, 2026. Abruzzo also serves as a Managing Director of the Delegated Sponsor. His previous Morgan Stanley roles included global Head of Enterprise Controls, global co-head of Foreign Exchange and Emerging Markets in the Fixed Income Division, and global head of the Futures and Derivatives Clearing business.
Morgan Stanley Solana Trust (MSOL) reported that Kaushik Goswami notified Morgan Stanley Investment Management Inc., the Delegated Sponsor of the Trust, of his intention to resign from his position as a director of the Delegated Sponsor, effective August 19, 2026.
The Trust itself remains in place, with Morgan Stanley Investment Management Inc. continuing to act as Delegated Sponsor. The filing does not describe any change to the Trust’s securities, which continue to trade as Common Shares of Beneficial Interest under the symbol MSOL on NYSE Arca, Inc.